MedTrace Logo

Growth Response in Girls With Turner Syndrome

NCT01734486 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2017-02-28

No results posted yet for this study

Summary

This trial is conducted in Europe. The aim of the trial is to evaluate growth response of two somatropin dose regimens in girls with Turner Syndrome.

Conditions

  • Genetic Disorder
  • Turner Syndrome

Interventions

DRUG

somatropin

0.9 UI/kg/week. Subcutaneous injection for 3 years

DRUG

somatropin

1.8 UI/kg/week. Subcutaneous injection for 3 years

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-09-23
Primary Completion
2003-05-21
Completion
2003-05-21

Countries

  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01734486 on ClinicalTrials.gov